Patents by Inventor Xiao Yonghong

Xiao Yonghong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7622292
    Abstract: Reagents that regulate human transmembrane serine protease activity and reagents that bind to human transmembrane serine protease gene products can be used to regulate extracellular matrix degradation. Such regulation is particularly useful for treating COPD, metastasis of malignant cells, tumor angiogenesis, inflammation, atherosclerosis, neurodegenerative diseases, and pathogenic infections.
    Type: Grant
    Filed: November 7, 2007
    Date of Patent: November 24, 2009
    Assignee: Bayer Schering Pharma AG
    Inventors: Xiao Yonghong, Richard W. Gedrich
  • Patent number: 7314730
    Abstract: Reagents that regulate human transmembrane serine protease activity and reagents that bind to human transmembrane serine protease gene products can be used to regulate extracellular matrix degradation. Such regulation is particularly useful for treating COPD, metastasis of malignant cells, tumor angiogenesis, inflammation, atherosclerosis, neurodegenerative diseases, and pathogenic infections.
    Type: Grant
    Filed: March 23, 2004
    Date of Patent: January 1, 2008
    Assignee: Bayer Aktiensegellschaft
    Inventors: Xiao Yonghong, Richard W. Gedrich
  • Publication number: 20040209327
    Abstract: Reagents that regulate human transmembrane serine protease activity and reagents that bind to human transmembrane serine protease gene products can be used to regulate extracellular matrix degradation. Such regulation is particularly useful for treating COPD, metastasis of malignant cells, tumor angiogenesis, inflammation, atherosclerosis, neurodegenerative diseases, and pathogenic infections.
    Type: Application
    Filed: March 23, 2004
    Publication date: October 21, 2004
    Applicant: Bayer Aktiensegellschaft
    Inventors: Xiao Yonghong, Richard W. Gedrich
  • Publication number: 20030109673
    Abstract: Reagents which regulate human HM74-like G protein coupled receptor can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, infections such as bacterial, fungal, protozoan, and viral infections, particularly those caused by HIV viruses, pain, cancers, anorexia, bulimia, asthma, CNS diseases such as Parkinson's disease, cardiovascular diseases such as acute heart failure, hypotension, hypertension, angina pectoris, and myocardial infarction, urinary retention, osteoporosis, ulcers, asthma, inflammation, allergies, multiple sclerosis, benign prostatic hypertrophy, and psychotic and neurological disorders, including anxiety, schizophrenia, manic depression, delirium, dementia, several mental retardation, and dyskinesias, such as Huntington's disease and Tourett's syndrome.
    Type: Application
    Filed: October 4, 2002
    Publication date: June 12, 2003
    Inventor: Xiao Yonghong